VNDA Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.

$11.18  +0.28 (2.52%)
As of 07/01/2022 15:59:55 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/12/2006
Outstanding shares:  56,489,712
Average volume:  630,502
Market cap:   $612,913,375
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B12W3P6

---

Valuation   (See tab for details)

---

PE ratio:   34.07
PB ratio:   1.23
PS ratio:   2.30
Return on equity:   3.60%
Net income %:   6.79%